|
Joseph Klein III is currently Managing Director of Gauss Capital Advisors, LLC, a financial consulting and investment advisory firm focused on biopharmaceutical companies, which he founded in March 1998. In addition to his investment advisory and financial consulting activities, Mr. Klein currently serves as a Venture Partner of Red Abbey Venture Partners, LP, a life sciences private equity fund. As an active life sciences investor and industry analyst, Mr. Klein has over 15 years of experience finding and analyzing life sciences opportunities for mutual funds, investment banks and biopharmaceutical companies. Mr. Klein serves on the board of directors of four publicly traded biotechnology companies: Biomarin Pharmaceutical, Inc.; Clinical Data, Inc.; ISIS Pharmaceuticals, Inc. and NPS Pharmaceuticals, Inc. Mr. Klein earned his B.A. in economics from Yale University and his M.B.A. from the Stanford Graduate School of Business. | 